Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

First patients enrolled in phase I study of PTP-001 as treatment of knee OA

March 12, 2021

Topline phase II data on C-21 in patients with systemic sclerosis and Raynaud's phenomenon

March 11, 2021

FDA clears initiation of phase I study of TTAX-03 for facet joint pain in osteoarthritis

March 10, 2021

Galapagos reports interim data from safety studies of filgotinib

March 4, 2021

Anti-TNF-alpha antibodies presented by Sinocelltech

March 2, 2021

Platelets release antigenic DNA in lupus

Feb. 25, 2021

Flexion advances FX-201 into high-dose cohort of phase I study in patients with knee osteoarthritis

Feb. 19, 2021

FDA approves IND for Signature Cord Prime in symptomatic knee osteoarthritis

Feb. 18, 2021

FDA accepts IND application for StroMel in osteoarthritis of knee

Feb. 18, 2021

Dana-Farber Cancer Institute describes new CDK7/cyclin H inhibitors

Feb. 16, 2021

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...